Loeb P M, Strober W, Falchuk Z M, Laster L
J Clin Invest. 1971 Mar;50(3):559-69. doi: 10.1172/JCI106525.
Incorporation of L-leucine-(14)C into proteins and immunoglobulins in vitro was determined in jejunal biopsy specimens from normal volunteers, patients with celiac sprue before and after introduction of gluten into the diet, patients with Whipple's disease in remission, and patients with immune deficiency states. Values for incorporation of L-leucine-(14)C into total and soluble protein by biopsies from five celiac sprue patients on a gluten-free diet were within, or slightly above, the 95% confidence limits for control data. One patient with celiac sprue and with normal intestinal histology had a normal value for incorporation into IgA; the other four patients with flat mucosas had elevated values. In Whipple's disease in remission, values for incorporation into total protein and IgA were within the control limits, whereas incorporation into soluble protein was increased. Patients with hypogammaglobulinemia or IgA deficiency had normal or elevated values for incorporation into total and soluble proteins; in these cases, however, no incorporation into IgA was detected. Biopsies from the four celiac sprue patients studied revealed that with introduction of gluten into the diet (a) incorporation into total protein, soluble protein, or both, increased; (b) incorporation into IgA increased in all patients, and in two instances the increase was greater than the increase in incorporation into total protein; and (c) incorporation into IgM increased in all patients. The changes during gluten administration usually occurred before changes in gastrointestinal absorptive function or in concentration of IgA in serum could be detected. These results indicate that gluten challenge stimulates increased local intestinal synthesis of immunoglobulins in patients with celiac sprue. The reaction occurs within days and it is possible that it plays a primary role in the pathogenesis of the disease.
在体外测定了正常志愿者、麸质引入饮食前后的乳糜泻患者、缓解期惠普尔病患者以及免疫缺陷状态患者空肠活检标本中L-亮氨酸-(14)C掺入蛋白质和免疫球蛋白的情况。五名接受无麸质饮食的乳糜泻患者活检标本中L-亮氨酸-(14)C掺入总蛋白和可溶性蛋白的值在对照数据的95%置信限内或略高于该范围。一名肠道组织学正常的乳糜泻患者IgA掺入值正常;另外四名黏膜扁平的患者该值升高。在缓解期的惠普尔病中,总蛋白和IgA的掺入值在对照范围内,而可溶性蛋白的掺入增加。低丙种球蛋白血症或IgA缺乏患者总蛋白和可溶性蛋白的掺入值正常或升高;然而,在这些病例中未检测到IgA的掺入。对四名接受研究的乳糜泻患者的活检显示,随着麸质引入饮食:(a)总蛋白、可溶性蛋白或两者的掺入增加;(b)所有患者IgA的掺入增加,在两个病例中,增加幅度大于总蛋白掺入的增加幅度;(c)所有患者IgM的掺入增加。麸质给药期间的变化通常在检测到胃肠道吸收功能或血清中IgA浓度变化之前就已发生。这些结果表明,麸质激发刺激了乳糜泻患者肠道局部免疫球蛋白合成增加。这种反应在数天内发生,并且有可能在该疾病的发病机制中起主要作用。